Light-twisting chiral nanotechnology could accelerate drug screening
In a new drug screening technique that relies on gold nanorods to twist light, a red glow can signal the failure of a medication being designed to treat amyloid diseases such as Type II diabetes and pancreatic cancer.
In a new drug screening technique that relies on gold nanorods to twist light, a red glow can signal the failure of a medication being designed to treat amyloid diseases such as Type II diabetes and pancreatic cancer.
No comments:
Post a Comment